Logo des HTGF

Portfolio Jobs

Browse through our portfolio jobs and select a suitable opportunity.

Our HTGF Portfolio of startups offers excellent opportunities and is always hiring talented people.

0
COMPANIES
0
JOBS

Scientist Toxicology (m/f/d)

Tubulis Technologies

Tubulis Technologies

Munich, Germany · Germany · Bavaria, Germany
Posted on Oct 17, 2025
Be part of our team
The Toxicology team at Tubulis is dedicated to ensuring the safety and efficacy of our innovative antibody-drug conjugates (ADCs) through rigorous preclinical studies. As a critical component of Tubulis’ Research and Development organization, our team collaborates closely with cross-functional groups, including Research, Early Development, and Clinical Development, to generate high-quality data essential for regulatory submissions and clinical trial applications.
Our current focus is on designing and evaluating pharmacokinetic and toxicological studies to advance Tubulis’ lead candidates toward first-in-human trials. The team thrives in a collaborative, innovative, and supportive environment, fostering a culture of scientific curiosity, open communication, and a shared commitment to improving patient outcomes through cutting-edge biotechnology.
Your mission
  • Experience with rodents or NHPs, GLP, ADC/biologics development, or CRO coordination.
  • Basic statistical knowledge and additional data analysis tools.
  • Proactive attitude toward learning and problem-solving.
  • Assist in designing and executing PK and toxicology studies in rodents and non-human primates (NHPs).
  • Coordinate and monitor studies with external CROs, including occasional on-site visits.
  • Support preparation of study protocols and troubleshoot preclinical experiments.
  • Evaluate study data and prepare technical reports, presentations, and safety assessments.
  • Collaborate with cross-functional teams to ensure study outcomes align with project goals and regulatory requirements.
  • Maintain accurate records in compliance with GLP.
  • Stay updated on scientific literature and regulatory guidelines.
Your profile
Qualifications:
  • Bachelor’s or Master’s degree in biotechnology, veterinary science, biology, or related field.
  • ~3 years’ lab experience, preferably with animal studies, diagnostics, or biotech research.
  • Basic knowledge of pharmacology, toxicology, or preclinical study principles.
  • Proficient in GraphPad Prism and MS Office.
  • Strong organizational skills, attention to detail, and ability to work independently.
  • Fluent in English; willing to travel occasionally to CRO sites.
  • Passion for ethical animal research and collaborative teamwork.
Preferred Qualifications:
  • Experience with rodents or NHPs, GLP, ADC/biologics development, or CRO coordination.
  • Basic statistical knowledge and additional data analysis tools.
  • Proactive attitude toward learning and problem-solving.
Why us?
At Tubulis, curiosity and innovation drive us to transform cancer treatment. We are a fast-growing biotech where science meets passion—and where you have the chance to grow with us.

  • Impact that matters: Contribute to breakthrough therapies.
  • Global mindset: Work in an international, diverse team.
  • Grow & thrive: Develop your career in a supportive, fast-moving environment.
  • Innovation every day: Push boundaries with cutting-edge science.
At Tubulis, your ideas matter, your growth matters—and together, we make a difference.
About us
The development of novel, effective and safe therapies for the treatment of cancer is one of the main challenges for modern medicine. We want to drive this process forward. The main goal of Tubulis is to become a leading company in the field of targeted therapeutics and antibody-drug conjugates (ADCs). With a strong team, our own technologies and innovative therapeutic concepts, we are ushering in a new era in the ongoing fight against cancer and share the vision of helping patients world-wide. Be part of a multidisciplinary and focused team, that works towards getting novel promising ADCs to patients with solid and hematological cancers.